ROSE Diagnostics, Inc. — Form C (Regulation Crowdfunding)
ROSE Diagnostics, Inc. of Carlsbad, CA filed a Form C (Regulation Crowdfunding) with the SEC on 2024-11-15. Target raise $124K, up to $1.2M. Offered through StartEngine Primary, LLC.
Offering
- Filed: 2024-11-15
- Form: C
- Accession: 0001665160-24-001629
- Target amount: $124K
- Maximum amount: $1.2M
- Security type: Other
- Securities offered: 4,299
- Price: $28.8400
- Deadline: 2025-02-13
- Funding portal / intermediary: StartEngine Primary, LLC
- Intermediary file number: 008-70060
Issuer
- CIK: 0002027716
- Website: https://rose-dx.com/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2023-07-21
- Address: 2796 Loker Avenue W Suite 104, Carlsbad, CA, 92010
- Employees: 1
Financials (as filed)
- Total assets (most recent): $6K
- Cash (most recent): $6K
- Net income (most recent): $-64K
People (6)
| Name | Role | Location |
|---|
| Adolfo Luis Velazquez-Dones | Board Member and Chief Technical Officer | CARLSBAD, CA |
| Eric Bertrand Brouwer | Board Member, Chief Scientific Officer | CARLSBAD, CA |
| Andrew Charles Morris | Board Member, Chief Executive Officer, Principal Accounting Officer | CARLSBAD, CA |
| Donna Thandu Padavan | Board Member and VP of Clinical and Regulatory Affairs | CARLSBAD, CA |
| Donna Thandu Padavan | Board Member and VP of Clinical & Regulatory Affairs | CARLSBAD, CA |
| Adolfo Luis Velazquez Dones | Board Member and Chief Technical Officer | CARLSBAD, CA |
Reg CF filing history (4)
More